MINE YOUR MIND
Confounding Factors in Treatment-Resistant Depression (Part 2): Comorbidities and Treatment Resistance
by Michael I. Casher, MD, Daniel Gih, MD, Joshua D. Bess, MD,
and Prachi Agarwala, MD |
August 3, 2012
Dr Casher is Director, Psychiatry Adult Inpatient Program, and Clinical Assistant Professor, department of psychiatry, University of Michigan Medical School, Ann Arbor. Dr Gih is Clinical Assistant Professor, Attending, Child and Adolescent Inpatient Psychiatry, University of Michigan Medical School. Dr Bess is Clinical Instructor, At-tending, Adult Inpatient Psychiatry, University of Michigan Medical School. Dr Agarwala is Child and Ado-lescent Psychiatry Hospitalist, Fairview Health Services, Minneapolis. Drs Casher and Bess are co-authors of Manual of Inpatient Psychiatry (Cambridge University Press, 2010), reviewed in Psychiatric Times, February 2011. Dr Casher reports that he is on the Speakers Bureau for Sunovion Pharmaceuticals and AstraZeneca. Drs Casher and Bess receive royalties from Cambridge University Press. Drs Gih, Bess, and Agarwala report no conflicts concerning the subject matter of this article.
1. Findings from the National Comorbidity Survey indicate that ____ of patients with a lifetime history of depression have a comorbid anxiety disorder.
2. Which of the following is associated with comorbid anxiety in depression?
A. More severe episodes of psychosis
B. Higher degree of neurocognitive problems
C. Greater risk of suicide
D. All of the above